NIS 2015 - 2015 : Novel Immunotherapeutics Summit
Topics/Call fo Papers
Novel Immunotherapeutics Summit, which will take place January 29 - 30, 2015 in San Diego, CA. The summit will bring together our usual balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain fresh perspective on the various research happening.
The Summit will begin with a plenary keynote session, and then break into four concurrent conferences, all of which will talk about complementary areas of the latest breakthroughs in the immunology field:
13th Cytokines & Inflammation
This meeting provides a forum for researchers to discuss the latest advances in targeting cytokines and chemokines for therapeutic interventions, cytokines and metabolism, and cytokines signaling pathways.
7th Immunotherapeutics & Immunomonitoring
Leading experts will cover recent advances in immunotherapy and how they relate to various immunotherapy modalities, specific cancers, cell subsets, animal models, and tumor microenvironment.
3rd Immunogenicity and Immunotoxicity
Delegates will learn about ongoing research for tools to mitigate risks associated with the immunogenicity of therapeutic proteins.
2nd Innate Immunity
Come learn about discoveries in toll like receptors, inflammasome reactions, the role of the microbiome and non-pathogenic bacteria, and many more.
The Summit will begin with a plenary keynote session, and then break into four concurrent conferences, all of which will talk about complementary areas of the latest breakthroughs in the immunology field:
13th Cytokines & Inflammation
This meeting provides a forum for researchers to discuss the latest advances in targeting cytokines and chemokines for therapeutic interventions, cytokines and metabolism, and cytokines signaling pathways.
7th Immunotherapeutics & Immunomonitoring
Leading experts will cover recent advances in immunotherapy and how they relate to various immunotherapy modalities, specific cancers, cell subsets, animal models, and tumor microenvironment.
3rd Immunogenicity and Immunotoxicity
Delegates will learn about ongoing research for tools to mitigate risks associated with the immunogenicity of therapeutic proteins.
2nd Innate Immunity
Come learn about discoveries in toll like receptors, inflammasome reactions, the role of the microbiome and non-pathogenic bacteria, and many more.
Other CFPs
Last modified: 2014-08-12 22:48:20